Site icon OncologyTube

Mallinckrodt and Terumo BCT Announce Positive Recommendations in Australia For Public Funding of Cellex and Uvadex – Next steps – Oscar Mesa MD MSC – Mallinckrodt @MNK #cutaneoustcelllymp…

Oscar Mesa, MD, MSC, Global Director, Health Economics, outcomes research and Market Access Critical care – Mallinckrodt discusses Mallinckrodt and Terumo BCT Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults

Exit mobile version